1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow PRETEXT IV Hepatoblastoma: new trials by email Literature Review of PRETEXT IV Hepatoblastoma trials Research Report on PRETEXT IV Hepatoblastoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Cisplatin, Dexrazoxane, Doxorubicin Hydrochloride - PRETEXT I Hepatoblastoma, PRETEXT II Hepatoblastoma | Phase 3 | Completed | National Cancer Institute (NCI) | 236 | 2009-09-15 | 2026-06-30 |
1,2-diaminocyclohexaneplatinum II citrate (1) · Cisplatin (1) · Dexrazoxane (1) · Doxorubicin (1) · Fluorouracil (1) · Irinotecan (1) · Liver Transplantation (1) · Platinum (1) · Razoxane (1) · Sirolimus (1) · Vincristine (1) · dehydroftorafur (1) · temsirolimus (1)
National Cancer Institute (NCI) (1)
Australia (1) · Brazil (1) · Canada (1) · Japan (1) · Puerto Rico (1) · United States (1)
PMID 30975630, PMID 34874751, PMID 37073741
U10CA098543 (1), U10CA180886 (1)